In reply #502, I made an error in my estimate of the peak monthly TruPulse
production. I quoted 78 units, but that was for the quarter; so the average
monthly rate was about 26 units.
So my fifth-to-last paragraph should have read:
"So how well has Palomar/Tissue done in expoiting this 400 unit, $20 million
backlog? Over the past 4 quarters, total Tissue revenue was $9.2 million.
Assuming all of this was due to lasers, and $50,000 per laser, then that is
equivalent to about 184 lasers. Either way, they revenued only about 46
percent of the announced $20 million backlog. Also, the peak monthly
production appears to have been about 26 units, in F'96 Q2, well below
Georgiev's forecast of 100 units. And in the most recent quarter, revenue
was equivalent to about 14 units!"
I believe this correction is important, in light of this claim in PMTI's
30 April 96 PR:
"Georgiev said that within three months Tissue Technologies will raise
production of its skin-resurfacing lasers to 100 a month from 50 a month
because of a backlog of 400 orders valued at about $20 million, the paper
reported.""
So it appears average production may never have exceeded about half of the
claimed existing 50 units per month, never mind reaching 100 units per month.
And it appears to have averaged less than 4 units per month in the most recent
quarter.
For more background and perspective on this, see reply #502.
Ted Molczan |
